Custom service

Peptide N-Terminal Modification

Modify the n-terminus with acyl groups, labels, spacers or cyclization handles

Turnaround: 2–4 weeksTypical scale: 0.5 mg – 1 g modified peptideChemistry options: N-acylation and carbamate caps; N-terminal label and linker installation; native chemical ligation handles

The service is built around N-acylation and carbamate caps. Depending on the molecule we may move to N-terminal label and linker installation or native chemical ligation handles to improve stability, loading or yield, and every batch is released with modified peptide with N-terminal confirmation by MS/MS.

Because Peptide N-Terminal Modification projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.

Half-life and stability tuning through N-capping

N-terminal attachment points for conjugation

N-terminal modifications requiring licensed proprietary caps

Modifications requiring radiological or BSL-3 containment

Modified peptides are released against a specification that includes site occupancy. Where a modification is labile (sulfation, glycosylation, phosphorylation), we use fragmentation data rather than mass shift alone to assign the site, and we state detection limits for any positional isomers that co-elute.

Service Highlights

  • N-acylation and carbamate caps as the default route, with N-terminal label and linker installation held as a proven fallback
  • Native chemical ligation handles worked into the design where the application requires it
  • Modification sites are mapped on the sequence and confirmed by MS/MS before release
  • Analytical confirmation of every intermediate before the final release
  • Modified and unmodified species are separated and quantified, not just reported
  • Modified peptide with N-terminal confirmation by MS/MS delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Sequence & modification map

    We annotate every modification site, protection strategy and analytical target before synthesis starts.

  2. Solid-phase assembly

    The chain is built with Fmoc chemistry, inserting modified or unnatural residues at the mapped positions.

  3. Modification chemistry

    Post-synthesis steps — N-acylation and carbamate caps, N-terminal label and linker installation — are run under conditions validated on a test cleavage.

  4. Cleavage & purification

    Global deprotection and cleavage are followed by RP-HPLC purification to the agreed purity.

  5. Analytical release

    Purity, identity and modification ratio are confirmed by HPLC, MS and MS/MS site mapping.

  6. Documentation

    Modified peptide with N-terminal confirmation by MS/MS is released with the batch record and analytical package after QC sign-off.

Specifications & timeline

Turnaround
2–4 weeks
Typical scale
0.5 mg – 1 g modified peptide
Chemistry options
N-acylation and carbamate caps; N-terminal label and linker installation; native chemical ligation handles
Deliverable
Modified peptide with N-terminal confirmation by MS/MS
QC package
HPLC purity, ESI/MALDI MS, MS/MS site mapping, modification ratio
Shipping
Ambient or blue ice as stability data dictate

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.